Sex‐specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population.

Background: Attention deficit hyperactivity disorder (ADHD) is more commonly diagnosed in males than in females. A growing body of research suggests that females with ADHD might be underdiagnosed or receive alternative diagnoses, such as anxiety or depression. Other lines of reasoning suggest that f...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Child Psychology & Psychiatry Vol. 59; no. 8; pp. 908 - 917
Autores principales: Martin, Joanna, Taylor, Mark J., Rydell, Mina, Riglin, Lucy, Eyre, Olga, Lu, Yi, Lundström, Sebastian, Larsson, Henrik, Thapar, Anita, Lichtenstein, Paul
Formato: Artículo
Publicado: Wiley-Blackwell Aug2018
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=130627911&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 130627911
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00219630
        JYY
      jtl: Journal of Child Psychology & Psychiatry
      issn: 00219630
      maglogo: Y
    pubinfo:
      dt: Aug2018
      vid: 59
      iid: 8
      pid: 480
      pub: Wiley-Blackwell
    artinfo:
      ui:
        130627911
        10.1111/jcpp.12874
      ppf: 908
      ppct: 9
      formats:
      tig:
        atl: Sex‐specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population.
      aug:
        au:
          Martin, Joanna
          Taylor, Mark J.
          Rydell, Mina
          Riglin, Lucy
          Eyre, Olga
          Lu, Yi
          Lundström, Sebastian
          Larsson, Henrik
          Thapar, Anita
          Lichtenstein, Paul
        affil:
          Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, Stockholm, Sweden
          MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK
          Institute of Neuroscience and Physiology, Gillberg Neuropsychiatry Centre, Centre for Ethics Law and Mental Health, University of Gothenburg, Gothenburg, Sweden
          School of Medical Sciences, Örebro University, Örebro, Sweden
      su:
        Diagnosis of mental depression
        Risk factors of attention-deficit hyperactivity disorder
        Attention-deficit hyperactivity disorder
        Medical screening
        Sex distribution
        Genetics
        Anxiety diagnosis
        Algorithms
        Confidence intervals
        Genetic polymorphisms
        Longitudinal method
        Odds ratio
        Symptoms
      sug:
        subj:
          Diagnosis of mental depression
          Risk factors of attention-deficit hyperactivity disorder
          Attention-deficit hyperactivity disorder
          Medical screening
          Sex distribution
          Genetics
          All Other Miscellaneous Ambulatory Health Care Services
          Anxiety diagnosis
          Algorithms
          Confidence intervals
          Genetic polymorphisms
          Longitudinal method
          Odds ratio
          Symptoms
      keyword:
        ADHD
        ALSPAC
        anxiety
        CATSS
        depression
        genetics
        ADHD
        ALSPAC
        anxiety
        CATSS
        depression
        genetics
      ab: Background: Attention deficit hyperactivity disorder (ADHD) is more commonly diagnosed in males than in females. A growing body of research suggests that females with ADHD might be underdiagnosed or receive alternative diagnoses, such as anxiety or depression. Other lines of reasoning suggest that females might be protected from developing ADHD, requiring a higher burden of genetic risk to manifest the disorder. Methods: We tested these two hypotheses, using common variant genetic data from two population‐based cohorts. First, we tested whether females and males diagnosed with anxiety or depression differ in terms of their genetic risk for ADHD, assessed as polygenic risk scores (PRS). Second, we tested whether females and males with ADHD differed in ADHD genetic risk burden. We used three different diagnostic definitions: registry‐based clinical diagnoses, screening‐based research diagnoses and algorithm‐based research diagnoses, to investigate possible referral biases. Results: In individuals with a registry‐based clinical diagnosis of anxiety or depression, females had higher ADHD PRS than males [OR(CI) = 1.39 (1.12–1.73)] but there was no sex difference for screening‐based [OR(CI) = 1.15 (0.94–1.42)] or algorithm‐based [OR(CI) = 1.04 (0.89–1.21)] diagnoses. There was also no sex difference in ADHD PRS in individuals with ADHD diagnoses that were registry‐based [OR(CI) = 1.04 (0.84–1.30)], screening‐based [OR(CI) = 0.96 (0.85–1.08)] or algorithm‐based [OR(CI) = 1.15 (0.78–1.68)]. Conclusions: This study provides genetic evidence that ADHD risk may be more likely to manifest or be diagnosed as anxiety or depression in females than in males. Contrary to some earlier studies, the results do not support increased ADHD genetic risk in females with ADHD as compared to affected males.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N